GlassScriptPhysician profile
Nadia Piccolo
NPI 1205451259
$709.45
in general payments reported to CMS, 2019-2025
12 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $230 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $170.60 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $148.47 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.17 | 2024-2025 | Lifevest |
| Pfizer INC. | $79.07 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $50.56 | 2025 | Verquvo |
| Chiesi USA, INC. | $31.23 | 2025 | Kengreal, Cleviprex |
| Novartis Pharmaceuticals Corporation | $30.17 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $23.09 | 2025 | Amvuttra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.91 | 2025 | Jardiance |
| Inari Medical, INC. | $17.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lilly USA, LLC | $16.56 | 2024 | Jardiance, Zepbound |
| United Therapeutics Corporation | $15.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Piccolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.